Search
for
Sort by
Research 421–450 of 1000+
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Patients’ knowledge, attitude, and practice regarding alopecia: a cross-sectional study in Hebei, China
- The 100 most cited articles in androgenetic alopecia: A bibliometric analysis
- Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- Is there a POST‐COVID dermatological syndrome? The integrated dermato‐infectious disease experience of a single centre
- Eflúvio Telógeno pós-COVID: uma revisão integrativa
- Assessment of The Long-Term Negative Impact of Bariatric Surgery on Health in Saudi Adults, over 3 Years after Surgery: A Cross-Sectional Study
- Current Topics in Post-COVID Syndromes
- The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit
- Annual Convention in the Time of COVID
- FEATURES OF THE DEVELOPMENT OF ACUTE DIFFUSE TELOGEN EFFLUVIUM IN PATIENTS WITH POST-COVID SYNDROME
- Aesthetic dermatology procedures in coronavirus days
- Facial Dermatoses in the Age of Masks: Acne, Eczema and the New Maskne
- Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea
- Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Dermatology practice in a high-tech world
- Hypothalamic-pituitary-adrenal axis, hair, and sebum: Stress-mediated dermatologic disasters of the pandemic era
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- Beyond ECMO Survival: Long-Term Symptom Burden and Quality-of-Life Impairment in Hantavirus Cardiopulmonary Syndrome Survivors
- Dermatological complications due to post‑COVID‑19 syndrome: A systematic review
- The rise of direct‐to‐consumer telemedicine services in Australia: implications for primary care and future research